Work

Should continuous glucose monitoring redefine prediabetes?

Year: 2026
Type: article
Abstract: Prediabetes is a clinically useful but biologically heterogeneous risk state defined by episodic laboratory thresholds that identify overlapping rather than identical populations. Continuous glucose monitoring can reveal temporal glycaemic variation that fasting plasma glucose, OGTT and HbA 1c cannot capture. Recent evidence indicates that sensor-derived metrics distinguish conventionally defined prediabetes from normoglycaemia and can stratify future glycaemic risk, making eventual incorporation into classification scientifically plausible. The case for immediate diagnostic use, however, is not established. Continuous glucose monitoring measures interstitial rather than venous plasma glucose; device performance and sampling duration influence the derived metrics; and treatment-oriented glucose targets were not developed as diagnostic cut-offs in people without diabetes. Before a continuous glucose monitoring phenotype can be incorporated into the definition of prediabetes, it should demonstrate reproducibility over time and across devices, provide clinically meaningful information beyond established tests and risk factors, change a management decision and show a favourable downstream balance between benefit and harm. Until these conditions are met, continuous glucose monitoring is better positioned as an instrument for phenotyping and risk stratification than as an independent diagnostic criterion.
Source: Diabetologia
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,490
OpenAlex ID: W7230506013
FWCI:
Cites: 25
Cited by:
Related to: 10